Prediction of residual disease using circulating DNA detection after potentiated radiotherapy for locally advanced head and neck cancer (NeckTAR): a study protocol for a prospective, multicentre trial.
Angeline GinzacMarie-Céleste FerreiraAnne CayreClément BouvetJulian BiauIoana MolnarNicolas SaroulNathalie Pham-DangXavier DurandoMaureen BernadachPublished in: BMC cancer (2023)
, 2022.
Keyphrases
- study protocol
- clinical trial
- circulating tumor
- early stage
- phase iii
- phase ii
- loop mediated isothermal amplification
- cell free
- randomized controlled trial
- locally advanced
- single molecule
- radiation therapy
- real time pcr
- double blind
- label free
- cross sectional
- squamous cell carcinoma
- open label
- nucleic acid
- sensitive detection
- circulating tumor cells
- quantum dots